Pharmacy Options for Purchasing Generic Tadalafil

We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale.

Understanding ED

We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding Teva's tadalafil tablets, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: The uncertainty of the commercial success of our generic version of tadalafil, including due to a potential launch of an Authorized Generic version; our ability to successfully compete in the marketplace, including: that we are substantially dependent on our generic products; competition for our specialty products, especially COPAXONE®, our leading medicine, which faces competition from existing and potential additional generic versions and orally-administered alternatives; competition from companies with greater resources and capabilities; efforts of pharmaceutical companies to limit the use of generics including through legislation and regulations; consolidation of our customer base and commercial alliances among our customers; the increase in the number of competitors targeting generic opportunities and seeking U.S.

Taking Cialis with food

market exclusivity for generic versions of significant products; price erosion relating to our products, both from competing products and increased regulation; delays in launches of new products and our ability to achieve expected results from investments in our product pipeline; our ability to take advantage of high-value opportunities; the difficulty and expense of obtaining licenses to proprietary technologies; and the effectiveness of our patents and other measures to protect our intellectual property rights; our substantially increased indebtedness and significantly decreased cash on hand, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments, and may result in a further downgrade of our credit ratings; and our inability to raise debt or borrow funds in amounts or on terms that are favorable to us; our business and operations in general, including: failure to effectively execute the restructuring plan announced in December 2017; uncertainties related to, and failure to achieve, the potential benefits and success of our new senior management team and organizational structure; harm to our pipeline of future products due to the ongoing review of our R&D programs; our ability to develop and commercialize additional pharmaceutical products; potential additional adverse consequences following our resolution with the U.S. government of our FCPA investigation; compliance with sanctions and other trade control laws; manufacturing or quality control problems, which may damage our reputation for quality production and require costly remediation; interruptions in our supply chain; disruptions of our or third party information technology systems or breaches of our data security; the failure to recruit or retain key personnel; variations in intellectual property laws that may adversely affect our ability to manufacture our products; challenges associated with conducting business globally, including adverse effects of political or economic instability, major hostilities or terrorism; significant sales to a limited number of customers in our U.S. market; our ability to successfully bid for suitable acquisition targets or licensing opportunities, or to consummate and integrate acquisitions; and our prospects and opportunities for growth if we sell assets; compliance, regulatory and litigation matters, including: costs and delays resulting from the extensive governmental regulation to which we are subject; the effects of reforms in healthcare regulation and reductions in pharmaceutical pricing, reimbursement and coverage; governmental investigations into sales and marketing practices; potential liability for patent infringement; product liability claims; increased government scrutiny of our patent settlement agreements; failure to comply with complex Medicare and Medicaid reporting and payment obligations; and environmental risks; other financial and economic risks, including: our exposure to currency fluctuations and restrictions as well as credit risks; potential impairments of our intangible assets; potential significant increases in tax liabilities; and the effect on our overall effective tax rate of the termination or expiration of governmental programs or tax benefits, or of a change in our business; and other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2017, including in the section captioned “Risk Factors,” and in our other filings with the U.S. Securities and Exchange Commission, which are available at and Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Bottom Line

1 Cialis® is a registered trademark of Eli Lilly and Company. Teva Pharmaceutical Industries Ltd.IR ContactsUnited StatesKevin C. Mannix, 215-591-8912orIsraelRan Meir, 215-591-3033orPR ContactsUnited StatesElizabeth DeLuca, 267-468-4329orIsraelYonatan Beker, 972 (54) 888 5898 Get 25% off on 1st online pharmacy purchase. It increases blood flow to specific areas of the body, including the penis, which helps achieve and maintain an erection when sexually stimulated. In men with BPH, it helps relax the muscles of the bladder and prostate, thereby improving urinary symptoms. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding Teva's tadalafil tablets, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: The uncertainty of the commercial success of our generic version of tadalafil, including due to a potential launch of an Authorized Generic version; our ability to successfully compete in the marketplace, including: that we are substantially dependent on our generic products; competition for our specialty products, especially COPAXONE®, our leading medicine, which faces competition from existing and potential additional generic versions and orally-administered alternatives; competition from companies with greater resources and capabilities; efforts of pharmaceutical companies to limit the use of generics including through legislation and regulations; consolidation of our customer base and commercial alliances among our customers; the increase in the number of competitors targeting generic opportunities and seeking U.S. market exclusivity for generic versions of significant products; price erosion relating to our products, both from competing products and increased regulation; delays in launches of new products and our ability to achieve expected results from investments in our product pipeline; our ability to take advantage of high-value opportunities; the difficulty and expense of obtaining licenses to proprietary technologies; and the effectiveness of our patents and other measures to protect our intellectual property rights; our substantially increased indebtedness and significantly decreased cash on hand, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments, and may result in a further downgrade of our credit ratings; and our inability to raise debt or borrow funds in amounts or on terms that are favorable to us; our business and operations in general, including: failure to effectively execute the restructuring plan announced in December 2017; uncertainties related to, and failure to achieve, the potential benefits and success of our new senior management team and organizational structure; harm to our pipeline of future products due to the ongoing review of our R&D programs; our ability to develop and commercialize additional pharmaceutical products; potential additional adverse consequences following our resolution with the U.S. government of our FCPA investigation; compliance with sanctions and other trade control laws; manufacturing or quality control problems, which may damage our reputation for quality production and require costly remediation; interruptions in our supply chain; disruptions of our or third party information technology systems or breaches of our data security; the failure to recruit or retain key personnel; variations in intellectual property laws that may adversely affect our ability to manufacture our products; challenges associated with conducting business globally, including adverse effects of political or economic instability, major hostilities or terrorism; significant sales to a limited number of customers in our U.S. market; our ability to successfully bid for suitable acquisition targets or licensing opportunities, or to consummate and integrate acquisitions; and our prospects and opportunities for growth if we sell assets; compliance, regulatory and litigation matters, including: costs and delays resulting from the extensive governmental regulation to which we are subject; the effects of reforms in healthcare regulation and reductions in pharmaceutical pricing, reimbursement and coverage; governmental investigations into sales and marketing practices; potential liability for patent infringement; product liability claims; increased government scrutiny of our patent settlement agreements; failure to comply with complex Medicare and Medicaid reporting and payment obligations; and environmental risks; other financial and economic risks, including: our exposure to currency fluctuations and restrictions as well as credit risks; potential impairments of our intangible assets; potential significant increases in tax liabilities; and the effect on our overall effective tax rate of the termination or expiration of governmental programs or tax benefits, or of a change in our business; and other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2017, including in the section captioned “Risk Factors,” and in our other filings with the U.S. Securities and Exchange Commission, which are available at and Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise.

You are cautioned not to put undue reliance on these forward-looking statements. 1 Cialis® is a registered trademark of Eli Lilly and Company. Teva Pharmaceutical Industries Ltd.IR ContactsUnited StatesKevin C. Mannix, 215-591-8912orIsraelRan Meir, 215-591-3033orPR ContactsUnited StatesElizabeth DeLuca, 267-468-4329orIsraelYonatan Beker, 972 (54) 888 5898 Get 25% off on 1st online pharmacy purchase. It increases blood flow to specific areas of the body, including the penis, which helps achieve and maintain an erection when sexually stimulated.

What happens if I overdose?

In men with BPH, it helps relax the muscles of the bladder and prostate, thereby improving urinary symptoms.

• The FDA regulates the production and sale of generic Cialis to ensure safety.
• Generic Cialis tablets are often identical in appearance and strength.
• Some minor differences in excipients may exist in generics but do not affect efficacy.
• Generic Cialis offers a more affordable option for long-term ED treatment.

For erectile dysfunction, tadalafil is commonly taken at doses of 5–20 mg by mouth as needed prior to sexual activity, or as 2.5–5 mg taken once daily. In benign prostatic hyperplasia (BPH), the typical dose is 5 mg by mouth once daily. Tadalafil’s mechanism involves relaxing blood vessels and improving blood flow, which assists in achieving and maintaining an erection. Tadalafil is recognized for its long-lasting effects, typically providing relief from erectile symptoms for up to 36 hours. This extended duration has earned it the nickname “the weekend pill.” Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.

The Pharmacy

Cialis provides relief to patients by leveraging its unique pharmacologic properties. Its effectiveness is attributed to its targeted molecular action and its specific pathway within the body. Cialis functions by inhibiting the enzyme phosphodiesterase type 5 (PDE5). This enzyme is located in various tissues, including the smooth muscle of the penis. By blocking PDE5, Cialis prevents the breakdown of cyclic guanosine monophosphate (cGMP), a molecule that relaxes smooth muscle cells and increases blood flow.

How Long Does It Take For Results?

The raised levels of cGMP facilitate an erection in response to sexual stimulation. For BPH, the same muscle-relaxing effect eases urinary symptoms by reducing tension in the urethra and bladder. Once administered, Cialis is absorbed from the gastrointestinal tract, with maximum blood concentrations reached roughly two hours post-ingestion. Cialis is metabolized predominantly by the liver and excreted primarily as inactive forms in the feces and urine. Its long half-life results in a prolonged duration of action, providing therapeutic effects that can last up to 36 hours.

How should I store tadalafil?

This extended action allows for more spontaneous sexual activity, without the need to plan around medication timing. Cialis offers flexibility in dosing and administration to accommodate individual needs and preferences. Understanding and following proper dosage guidelines helps maximize its benefits while minimizing potential side effects. For Erectile Dysfunction: A starting dose of 10 mg prior to anticipated sexual activity is recommended. Cialis is a prescription medication commonly used to treat erectile dysfunction (ED) and the symptoms of benign prostatic hyperplasia (BPH) in men. This medication has gained popularity for its extended duration of action, which distinguishes it from other medications in the same class.

• Generic Cialis contains the same active ingredient, tadalafil, as brand-name Cialis.
• Generic versions are usually less expensive than the brand-name medication.
• FDA approved generic Cialis must meet strict manufacturing standards.
• Many pharmacies offer generic Cialis options for ED treatment.

Additionally, Cialis is marketed under the brand name Adcirca for the treatment of pulmonary arterial hypertension. Cialis is employed in various therapeutic settings beyond its primary uses. It effectively addresses conditions cialis soft gel related to sexual and urinary health, thereby broadening its applicability. Erectile Dysfunction (ED): Cialis helps men achieve and maintain erections sufficient for sexual activity by enhancing blood flow to the penis. Benign Prostatic Hyperplasia (BPH): Used to relieve symptoms of BPH, such as difficulty urinating, by relaxing muscles in the prostate and bladder. Pulmonary Arterial Hypertension (marketed as Adcirca): Used to improve exercise capacity in individuals with this condition by dilating blood vessels in the lungs, lowering blood pressure within the lungs.

• The active ingredient in generic Cialis, tadalafil, works the same way as in the original.
• Brand-name Cialis is protected by patents, which generics can only enter after expiry.
• Purchasing from reputable sources ensures the generic Cialis's quality.
• Generic Cialis provides a similar relief for erectile dysfunction as the original.

Apart from these primary indications, Cialis is also being explored for several off-label uses: Raynaud’s Phenomenon: It may help alleviate symptoms by improving blood flow to the fingers and toes.

Female Sexual Arousal Disorder: Under medical supervision, it may be used to address sexual arousal issues in women, though this is not an officially approved indication. Cialis provides relief to patients by leveraging its unique pharmacologic properties. Its effectiveness is attributed to its targeted molecular action and its specific pathway within the body.

Comparing Which Works Faster

For erectile dysfunction, tadalafil is commonly taken at doses of 5–20 mg by mouth as needed prior to sexual activity, or as 2.5–5 mg taken once daily. In benign prostatic hyperplasia (BPH), the typical dose is 5 mg by mouth once daily. Tadalafil’s mechanism involves relaxing blood vessels and improving blood flow, which assists in achieving and maintaining an erection. Tadalafil is recognized for its long-lasting effects, typically providing relief from erectile symptoms for up to 36 hours. This extended duration has earned it the nickname “the weekend pill.” Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.

Drug forms and administration

Cialis is a prescription medication commonly used to treat erectile dysfunction (ED) and the symptoms of benign prostatic hyperplasia (BPH) in men. This medication has gained popularity for its extended duration of action, which distinguishes it from other medications in the same class. Additionally, Cialis is marketed under the brand name Adcirca for the treatment of pulmonary arterial hypertension. Cialis is employed in various therapeutic settings beyond its primary uses. It effectively addresses conditions cialis soft gel related to sexual and urinary health, thereby broadening its applicability.

How long does tadalafil last?

Erectile Dysfunction (ED): Cialis helps men achieve and maintain erections sufficient for sexual activity by enhancing blood flow to the penis. Benign Prostatic Hyperplasia (BPH): Used to relieve symptoms of BPH, such as difficulty urinating, by relaxing muscles in the prostate and bladder. Pulmonary Arterial Hypertension (marketed as Adcirca): Used to improve exercise capacity in individuals with this condition by dilating blood vessels in the lungs, lowering blood pressure within the lungs. Apart from these primary indications, Cialis is also being explored for several off-label uses: Raynaud’s Phenomenon: It may help alleviate symptoms by improving blood flow to the fingers and toes. Female Sexual Arousal Disorder: Under medical supervision, it may be used to address sexual arousal issues in women, though this is not an officially approved indication. Cialis functions by inhibiting the enzyme phosphodiesterase type 5 (PDE5). This enzyme is located in various tissues, including the smooth muscle of the penis. By blocking PDE5, Cialis prevents the breakdown of cyclic guanosine monophosphate (cGMP), a molecule that relaxes smooth muscle cells and increases blood flow. The raised levels of cGMP facilitate an erection in response to sexual stimulation. For BPH, the same muscle-relaxing effect eases urinary symptoms by reducing tension in the urethra and bladder. Once administered, Cialis is absorbed from the gastrointestinal tract, with maximum blood concentrations reached roughly two hours post-ingestion. Cialis is metabolized predominantly by the liver and excreted primarily as inactive forms in the feces and urine.

Start With a Reputable Practitioner.

Its long half-life results in a prolonged duration of action, providing therapeutic effects that can last up to 36 hours. This extended action allows for more spontaneous sexual activity, without the need to plan around medication timing.

Cialis offers flexibility in dosing and administration to accommodate individual needs and preferences. Understanding and following proper dosage guidelines helps maximize its benefits while minimizing potential side effects. For Erectile Dysfunction: A starting dose of 10 mg prior to anticipated sexual activity is recommended.